Researchers find a promising approach to remove amyloid plaques in Alzheimer’s disease

FHS
April 3, 2024
7:06 pm

Alzheimer’s disease starts with a sticky protein called amyloid beta that builds up into plaques in the brain, setting off a chain of events that results in brain atrophy and cognitive decline.

Triple negative breast cancer unmet treatment needs

TNBC drugs by development stage. Credit: GlobalData. Triple negative breast cancer (TNBC) is characterised by a lack of clinically significant expression levels of oestrogen receptor,

July 10, 2023

FDA OKs First Drug Targeting NRG1 Gene Fusion in Pancreatic, Lung Cancers

The FDA granted accelerated approval to the bispecific antibody zenocutuzumab (Bizengri) for NRG1 gene fusion-positive pancreatic adenocarcinoma and non-small cell lung cancer (NSCLC) on Wednesday.

December 5, 2024

FDA places hold on Novavax’s Covid-flu and standalone influenza vaccines

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.